Cargando…
Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine
Gastric cancer (GC) is the fifth most frequently diagnosed cancer and the third leading cause of cancer death. Approximately 15% of GC is associated with Epstein–Barr virus (EBV). GC is largely incurable with a dismal five-year survival rate. There is an urgent need to identify new therapeutic agent...
Autores principales: | Ke, Xiangyu, Qin, Qingsong, Deng, Tianyi, Liao, Yueyan, Gao, Shou-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072542/ https://www.ncbi.nlm.nih.gov/pubmed/32033497 http://dx.doi.org/10.3390/cancers12020365 |
Ejemplares similares
-
Tenovin-6 impairs autophagy by inhibiting autophagic flux
por: Yuan, Hongfeng, et al.
Publicado: (2017) -
Correction: Tenovin-6 impairs autophagy by inhibiting autophagic flux
por: Yuan, Hongfeng, et al.
Publicado: (2018) -
The Second-Generation XPO1 Inhibitor Eltanexor Inhibits Human Cytomegalovirus (HCMV) Replication and Promotes Type I Interferon Response
por: Liao, Yueyan, et al.
Publicado: (2021) -
Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy
por: Yuan, Hongfeng, et al.
Publicado: (2017) -
Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6
por: MacCallum, Stephanie F., et al.
Publicado: (2013)